University of Tokyo Professor Says Results of Diovan Investigations Need to Be Made Open Globally

Prof. Kenji Shibuya Japan needs to globally share the results of its investigation into a clinical study scandal involving Diovan (valsartan), Novartis Pharma’s hypertension drug, a health policy professor at the University of Tokyo said. Such action is necessary to...read more